MiMedx Group, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CCCC
|
C4 Therapeutics, Inc. | $5.90 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $17.19 | $1.29 B | -7.16 | 85 | $0 |
 CNTA
|
Centessa Pharmaceuticals plc | $15.76 | $884.24 M | -6.2 | 72 | $6.88 M |
 CVKD
|
Cadrenal Therapeutics, Inc. Common Stock | $14.50 | $7.53 M | 0 | 4 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $14.16 | $1.12 B | -5.11 | 169 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.32 | $217.51 M | -3.7 | 57 | $0 |
 ERAS
|
Erasca, Inc. | $2.68 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.07 | $1.65 B | -11.47 | 97 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.17 | $243.38 M | -1.59 | 129 | $0 |
 GPCR
|
Structure Therapeutics Inc. | $41.72 | $2.47 B | -23.59 | 136 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $2.12 | $151.66 M | -3.17 | 45 | $19.94 M |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 18 | $9.16 M |
 INZY
|
Inozyme Pharma, Inc. | $5.18 | $286.39 M | -3.43 | 59 | $0 |
 IPSC
|
Century Therapeutics, Inc. | $1.61 | $244.54 M | -1.32 | 152 | $2.24 M |
 KROS
|
Keros Therapeutics, Inc. | $56.50 | $1.76 B | -9.45 | 149 | $151,000 |
 MLYS
|
Mineralys Therapeutics, Inc. | $11.91 | $652.38 M | -6.03 | 28 | $0 |
 NGM
|
NGM Biopharmaceuticals, Inc. | $1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
 NVCT
|
Nuvectis Pharma, Inc. | $6.14 | $116.38 M | -4.5 | 13 | $0 |
 PTGX
|
Protagonist Therapeutics, Inc. | $44.54 | $2.04 B | 13.7 | 125 | $60.00 M |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $18.90 | $1.66 B | -6.02 | 184 | $0 |
 STOK
|
Stoke Therapeutics, Inc. | $12.23 | $774.50 M | -6.14 | 110 | $8.78 M |
 ZNTL
|
Zentalis Pharmaceuticals, Inc. | $3.75 | $754.16 M | -3.26 | 124 | $0 |